At a glance: Bad news for Astra-Zeneca’s Exanta

AstraZeneca’s oral anticoagulant drug – what’s the story? The US Food and Drug Administration (FDA) last week refused approval for Exanta in any form. The company put forward three indications for the drug, including its use to treat blood clots after knee surgery.